Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prebiotic Supplementation in Celiac Disease: A Systematic Review of Clinical Efficacy, Safety, and Nutritional Outcomes.

Journal of gastrointestinal and liver diseases : JGLD·2026
Same author

Celiac Disease: A Comprehensive Review of Epidemiology, Pathogenesis, and Therapeutic Strategies.

Digestive diseases and sciences·2026
Same author

IBD Care Across Diverse Patient Populations: Changing the Narrative.

Digestive diseases and sciences·2026
Same author

The Great Masquerader: When Perianal Disease Isn't What It Seems.

Digestive diseases and sciences·2026
Same author

Hydrogen Peroxide Flushes for Necrotizing Pancreatitis in a High-Risk Surgical Patient: A Pathway for Durable Response Without Additional Endoscopic Intervention.

Case reports in gastrointestinal medicine·2025
Same author

Analgesic Management of Chronic Pancreatitis.

Digestive diseases and sciences·2025

Related Experiment Videos

Short-Term Psychiatric Risk After IBD Surgery: A Propensity Score-Matched Analysis by Disease Severity.

Vanessa Orbe1, Kofi Clarke2, Shannon Dalessio2

  • 1Penn State College of Medicine, Department of Medicine, Hershey, PA, USA.

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|July 10, 2026
PubMed
Summary
This summary is machine-generated.

Inflammatory bowel disease surgery increases anxiety and depression risk in patients on biologics, not 5-ASAs. This highlights the need for mental health support after surgery for advanced IBD patients.

Keywords:
anxietydepressioninflammatory bowel diseasesurgery

Related Experiment Videos

Area of Science:

  • Gastroenterology
  • Psychiatry
  • Health Services Research

Background:

  • Inflammatory bowel disease (IBD) is frequently linked with psychiatric conditions like anxiety and depression.
  • Previous research indicates a higher prevalence of mood disorders post-IBD surgery, but the precise risk and its relation to disease severity require further definition.

Purpose of the Study:

  • To investigate the association between IBD-related surgery and the short-term incidence of anxiety and depression.
  • To compare these risks based on different treatment strata: 5-aminosalicylates (5-ASAs) and biologics.

Main Methods:

  • A cohort study was conducted using the TriNetX US Collaborative Network, including adults aged 18-65 with newly diagnosed IBD from January 2016 to June 2020.
  • Patients undergoing IBD surgery within five years of diagnosis were matched with nonsurgical controls.
  • Primary outcomes included incident anxiety and depression within six months post-event, analyzed across 5-ASA and biologic treatment groups.

Main Results:

  • In the 5-ASA group (n=1,255 per arm), surgery showed no significant difference in anxiety (8.77% vs 8.05%) or depression (6.93% vs 5.10%) incidence.
  • In the biologic group (n=2,492 per arm), surgery was linked to significantly higher anxiety (12.08% vs 6.86%) and depression (6.74% vs 4.09%) rates.
  • The risk difference for anxiety and depression in the biologic group was statistically significant (p<0.0001 for both).

Conclusions:

  • IBD surgery is associated with increased short-term anxiety and depression risk, but only in patients treated with biologics.
  • The findings suggest that patients with more severe disease, often treated with biologics, may have a greater postoperative psychiatric vulnerability.
  • Perioperative mental health screening and support are crucial for IBD patients undergoing surgery, particularly those on advanced therapies.